Clinical Trial Update: Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is recruiting to evaluate tirzepatide as an adjunct to buprenorphine for the treatment of opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• MOUNJARO (tirzepatide)
• buprenorphine (buprenorphine)

Snippet

Sponsor: T. John Winhusen, PhD | Conditions: Opioid Use Disorder, Opioid Use Disorder, Moderate | Phase 2 | Status: RECRUITING